Shuttle Pharmaceuticals Holdings, Inc. SHPH
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 34.98% | 41.55% | 187.90% | -19.84% | 244.71% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.00% | -24.88% | 56.90% | -25.71% | 163.75% |
| Operating Income | -1.00% | 24.88% | -56.90% | 25.71% | -163.75% |
| Income Before Tax | 15.14% | 29.50% | -63.58% | 37.97% | -82.48% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 15.14% | 29.50% | -63.58% | 37.97% | -82.48% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 15.14% | 29.50% | -63.58% | 37.97% | -82.48% |
| EBIT | -1.00% | 24.88% | -56.90% | 25.71% | -163.75% |
| EBITDA | 31.37% | 24.89% | -40.78% | 25.73% | -163.91% |
| EPS Basic | 90.59% | 94.37% | 88.37% | -- | -- |
| Normalized Basic EPS | 88.33% | 94.37% | 86.85% | -- | -- |
| EPS Diluted | 90.59% | 94.37% | 90.52% | -- | -- |
| Normalized Diluted EPS | 88.33% | 94.37% | 86.85% | -- | -- |
| Average Basic Shares Outstanding | 801.60% | 1,151.74% | 1,306.09% | -- | -- |
| Average Diluted Shares Outstanding | 801.60% | 1,151.74% | 1,306.09% | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |